3488
|
(±)-CGP-12177A
|
β1/β2 adrenoceptor antagonist, β3 adrenoceptor agonist |
€120.00 |
3575
|
AMG510
|
Highly potent, selective, and orally bioavailable KRAS-G12C inhibitor |
€90.00 |
3433
|
ARB-272572
|
Potent, cellular active PD-L1 inhibitor |
€150.00 |
3568
|
Col003
|
Potent, competitive collagen-Hsp47 interaction inhibitor |
€110.00 |
3517
|
DSRM-3716
|
Potent and selective SARM1 NADase inhibitor |
€70.00 |
3584
|
GDC-0084
|
Brain-penetrant dual PI3K and mTOR inhibitor |
€110.00 |
3557
|
KPT-9274
|
Orally bioavailable dual PAK4/NAMPT inhibitor |
€130.00 |
3482
|
LDC7559
|
PFKL activator |
€155.00 |
3556
|
LXH254
|
Potent, selective and orally available type II B/C RAF inhibitor |
€180.00 |
3562
|
ML 324
|
Inhibitor of JMJD2 histone demethylase |
€90.00 |
3559
|
Myricetin
|
RNase L inhibitor |
€70.00 |
3572
|
Nicotinamide riboside chloride
|
NAD+ precursor |
€60.00 |
3571
|
NMN
|
NAD+ precursor |
€50.00 |
3578
|
O-Desmethylvenlafaxine
|
Metabolite of Venlafaxine; SNRI |
€70.00 |
3576
|
Riluzole hydrochloride
|
Glutamatergic neurotransmission blocker; neuroprotectant |
€80.00 |
3554
|
RP 70676
|
Potent and orally bioavailable ACAT inhibitor |
€210.00 |
3395
|
SGC-STK17B-1
|
Potent, selective and ATP-competitive STK17B inhibitor |
€95.00 |
3560
|
THZ1
|
Covalent CDK7 inhibitor |
€60.00 |
3558
|
Vericiguat
|
Potent and orally available sGC stimulator |
€140.00 |
3585
|
Vesatolimod
|
Potent, selective and orally available TLR7 agonist |
€80.00 |